-Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer

Press/Media

PeriodSep 15 2022

Media coverage

2

Media coverage

  • Title-Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date09/15/22
    PersonsIgor Astsaturov
  • Title-Lantern Pharma to Present Positive Preclinical Data on the Efficacy of LP-184 for Pancreatic Cancer at the AACR Special Conference for Pancreatic Cancer
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date09/15/22
    PersonsIgor Astsaturov